Pharma gives UCPMP the thumbs up, health activists cry foul Viveka Roychowdhury Mar 15, 2024 Health activists raise doubts on pharma associations self-monitoring the code
Uniform Code for Pharmaceutical Marketing Practices 2024 rolled out EP News Bureau Mar 13, 2024 It unequivocally prohibits pharma companies, agents, distributors, wholesalers, and retailers from offering or providing financial…
DOP amends PTUAS, expands eligibility criteria to include MSMEs EP News Bureau Mar 12, 2024 Offers flexible financing options, and focuses on reimbursement subsidies from 10-20 per cent to MSMEs
Targeted funding strategies and policy interventions are key to make rare disease treatments… Viveka Roychowdhury Mar 4, 2024 Coinciding with the recent observance of Rare Diseases Day on February 29, 2024, Anil Matai, Director General of OPPI, accentuated…
Complying with DPDP 2023 Diwakar Dayal Jan 12, 2024 Diwakar Dayal, Managing Director & Country Manager at SentinelOne explains the provisions of the Digital Personal Data…
MoHFW announces revised Schedule M under the Drugs (Amendment) Rules, 2023 EP News Bureau Jan 6, 2024 Small and medium manufacturers with an annual turnover of less than Rs 250 crore have 12 months to comply with the guidelines,…
Lex Witness to host 9th Annual Pharma Legal & Compliance Summit 2023 in Mumbai EP News Bureau Dec 4, 2023 The summit is scheduled for December 8, 2023 at the Courtyard by Marriott, Mumbai, Andheri East
Health Ministry releases draft National Pharmacy Commission Bill, 2023 PTI Nov 21, 2023 It seeks to repeal the Pharmacy Act of 1948 and replace the Pharmacy Council of India with a national commission
NPPA slashes prices on 33 FDCs drugs EP News Bureau Nov 15, 2023 This move affects pharma companies like JB Chemicals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharma, Sanofi India, and…
Dr Mansukh Mandaviya launches national R&D and Innovation Policy and PRIP scheme PIB Sep 26, 2023 The scheme will focus on transforming India into a high-volume, high-value player in the global market of pharmaceuticals, meeting…
NCLAT validates insolvency resolution process in Hindustan National Glass case EP News Bureau Sep 21, 2023 Recognises AGI Greenpac's acquisition of HNG
DCGI issues advisory about Digene Gel following Abbott’s voluntary recall EP News Bureau Sep 6, 2023 The advisory instructs healthcare professionals to promptly report any suspicious cases of adverse events linked to this product
US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment EP News Bureau Aug 22, 2023 The FDA action follows the previously announced discontinuation of the Phase 3 ENHANCE study of magrolimab in higher-risk…
Industry backlash may reshape EU compulsory pharma licensing reform: GlobalData EP News Bureau Aug 21, 2023 Both Johnson & Johnson and Pfizer criticised the changes by referencing the positive role of patents in incentivising their…